True North Advisors, LLC Merck & Co., Inc. Transaction History

True North Advisors, LLC

$378 Million
Q3 2024

A detailed history of True North Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, True North Advisors, LLC holds 10,742 shares of MRK stock, worth $1.07 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

10,742

Previous 10,742 -0.0%

Holding current value

$1.07 Million

Previous $1.33 Million 8.28%

% of portfolio

0.32%

Previous 0.36%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$123.8 - $132.96 $18,817 - $20,209	-152 Reduced 1.4%	10,742 $1.33 Million
Q1 2024 Apr 12, 2024	SELL	$113.24 - $131.95 $2,604 - $3,034	-23 Reduced 0.21%	10,894 $1.44 Million
Q4 2023 Jan 22, 2024	SELL	$100.18 - $109.02 $370,966 - $403,701	-3,703 Reduced 25.33%	10,917 $1.19 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $327,278 - $363,455	-3,179 Reduced 17.86%	14,620 $1.51 Million
Q2 2023 Aug 10, 2023	SELL	$108.61 - $118.38 $183,876 - $200,417	-1,693 Reduced 8.69%	17,799 $2.05 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $10,705 - $11,945	104 Added 0.54%	19,492 $2.07 Million
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $16,875 - $21,637	-193 Reduced 0.99%	19,388 $2.15 Million
Q3 2022 Nov 10, 2022	SELL	$84.53 - $94.96 $68,638 - $77,107	-812 Reduced 3.98%	19,581 $1.69 Million
Q2 2022 Jul 28, 2022	BUY	$83.49 - $94.64 $28,971 - $32,840	347 Added 1.73%	20,393 $1.86 Million
Q1 2022 May 12, 2022	BUY	$73.51 - $82.4 $3,528 - $3,955	48 Added 0.24%	20,046 $1.64 Million
Q4 2021 Feb 11, 2022	BUY	$72.28 - $90.54 $13,877 - $17,383	192 Added 0.97%	19,998 $1.53 Million
Q3 2021 Jun 07, 2022	BUY	$71.68 - $78.83 $64,440 - $70,868	899 Added 4.75%	19,806 $1.49 Million
Q2 2021 Jun 07, 2022	BUY	$70.31 - $77.77 $15,468 - $17,109	220 Added 1.18%	18,907 $1.47 Million
Q1 2021 Jun 07, 2022	SELL	$68.86 - $81.11 $4,751 - $5,596	-69 Reduced 0.37%	18,687 $1.44 Million
Q4 2020 May 20, 2022	SELL	$71.77 - $79.65 $237,630 - $263,721	-3,311 Reduced 15.0%	18,756 $1.53 Million
Q3 2020 May 20, 2022	BUY	$73.18 - $82.95 $65,715 - $74,489	898 Added 4.24%	22,067 $1.83 Million
Q2 2020 May 20, 2022	BUY	$70.42 - $80.13 $874,193 - $994,733	12,414 Added 141.79%	21,169 $1.64 Million
Q1 2020 May 12, 2022	BUY	$63.36 - $87.82 $1,837 - $2,546	29 Added 0.33%	8,755 $673,000
Q4 2019 May 12, 2022	BUY	$77.58 - $87.54 $676,963 - $763,874	8,726 New	8,726 $793,000

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of True North Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True North Advisors, LLC with notifications on news.

Account

True North Advisors, LLC Merck & Co., Inc. Transaction History